{"doi":"10.1016/j.bja.2023.10.041","title":"Clarifying intrinsic efficacy, partial agonism, and full agonism: the case of buprenorphine","abstract":null,"journal":"British Journal of Anaesthesia","year":2024,"id":596458,"datarank":0.26876392038420827,"base_score":1.791759469228055,"endowment":1.791759469228055,"self_citation_contribution":0.26876392038420827,"citation_network_contribution":0.0,"self_endowment_contribution":0.26876392038420827,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":5,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":435730,"name":"Damien S. K. Samways","orcid":"0000-0002-5349-146X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Clarifying intrinsic efficacy, partial agonism, and full agonism: the case of buprenorphine","abstract":null,"is_dataset_classified":null,"base_score":1.791759469228055,"endowment":1.791759469228055,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38042727","pmcid":null,"openalex_id":"https://openalex.org/W4389234808","authors":[],"funders":[],"total_grants":0,"fwci":1.217,"citation_percentile":0.79763235,"influential_citations":0,"citation_trend":[{"year":2024,"count":1},{"year":2025,"count":4}],"oa_status":"bronze","license":"http://www.elsevier.com/open-access/userlicense/1.0/","oa_locations":[{"url":"http://www.bjanaesthesia.org/article/S0007091223006360/pdf","host_type":"journal"},{"url":"http://www.bjanaesthesia.org/article/S0007091223006360/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0007091223006360?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0007091223006360?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.bja.2023.10.041","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38042727","host_type":"repository"}],"fields_of_study":["Opioid Use Disorder Treatment","Veterinary Pharmacology and Anesthesia","Neuropeptides and Animal Physiology","Humans","Buprenorphine","Analgesics, Opioid","Pain"],"mesh_terms":["Analgesics, Opioid","Buprenorphine","Humans","Pain"],"keywords":["Agonism","Psychology","Political science","buprenorphine","ceiling effect","intrinsic efficacy","opioid","partial agonist","pharmacodynamics","receptor reserve"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Zero hunger"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-28T10:18:29.911561Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}